Upstream Biotechnology closes seed round for on-demand crop defence
LeVert Ventures leads the seed round for the North Carolina plant biotech advancing its SwitchBlade crop defence platform.
Upstream Biotechnology, a North Carolina plant-biotechnology company, has closed an undisclosed seed financing led by LeVert Ventures, with participation from Corteva Catalyst, Silver Blue and VTC Ventures.
The funding will advance its SwitchBlade platform, which activates crop-resistance traits in response to disease or environmental stress rather than keeping them permanently switched on, an approach designed to avoid the yield penalty of constitutive defence expression.
Upstream Biotechnology, a North Carolina plant-biotechnology company, has closed an undisclosed seed financing led by LeVert Ventures, with participation from Corteva Catalyst, Silver Blue and VTC Ventures.
The funding will advance its SwitchBlade platform, which activates crop-resistance traits in response to disease or environmental stress rather than keeping them permanently switched on, an approach designed to avoid the yield penalty of constitutive defence expression.